Third Rock Ventures Iv, L.P. Fulcrum Therapeutics, Inc. (FULC) insider trading activity

Third Rock Ventures Iv, L.P. is > 10% Shareholder of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 2.34 Million shares of FULC, which is worth approximately $10.7 Million. The most recent transaction as insider was on Jul 22, 2019, when has been sold 81,250 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $1,300,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.34M

0% 3M change

0% 12M change

Total Value Held $10.7 Million

Third Rock Ventures IV, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 22 2019	BUY Open market or private purchase	$1,300,000 $16.0 p/Share	81,250 Added 3.35%	2,343,154 Common Stock
Jul 22 2019	BUY Conversion of derivative security	-	2,261,904 Added 50.0%	2,261,904 Common Stock

Also insider at

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

TNGX

Tango Therapeutics, Inc. Healthcare

MGTA

Magenta Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV